Brief: HLS Therapeutics Announces Q3 Fiscal 2021 Financial Results
04/11/2021 12:53
Nov 4 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES Q3 FISCAL 2021 FINANCIAL
RESULTS
* HLS THERAPEUTICS INC - Q3 2021 REVENUE OF $15.1 MILLION
* HLS THERAPEUTICS INC - Q3 2021 REVENUE WAS $15.1 MILLION
COMPARED TO $13.1 MILLION IN Q3 2020
* HLS THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.06
Source text for Eikon: ID:nCNWcQXSma
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group